share_log

AxoGen Insiders Sold US$639k Of Shares Suggesting Hesitancy

AxoGen Insiders Sold US$639k Of Shares Suggesting Hesitancy

Axogen內部人士出售了63.9萬美元的股票,表明他們有些猶豫。
Simply Wall St ·  07/17 19:31

A number of AxoGen, Inc. (NASDAQ:AXGN) insiders sold their shares in the last year, which may have raised concerns among investors. Knowing whether insiders are buying is usually more helpful when evaluating insider transactions, as insider selling can have various explanations. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.

在過去一年中,許多AxoGen,Inc. (NASDAQ:AXGN)的內部人士賣出了他們的股份,這可能引起了投資者的擔憂。在評估內部交易時,知道內部人士是否正在購買通常更有幫助,因爲內部人士出售股票可能有各種解釋。然而,當多名內部人士在特定時間內出售股票時,股東應該注意這可能是一個紅旗。

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.

雖然我們永遠不會建議投資者僅基於公司董事已經做出的決策而做出決策,但同時我們認爲完全忽略內部交易是愚蠢的。

The Last 12 Months Of Insider Transactions At AxoGen

AxoGen過去的12個月內的內部交易

In the last twelve months, the biggest single sale by an insider was when the insider, Michael Donovan, sold US$320k worth of shares at a price of US$8.81 per share. That means that even when the share price was below the current price of US$9.18, an insider wanted to cash in some shares. We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. However, while insider selling is sometimes discouraging, it's only a weak signal. It is worth noting that this sale was 50% of Michael Donovan's holding.

在過去的十二個月中,內部人士中最大的一筆單筆交易是內部人士Michael Donovan以每股8.81美元的價格出售價值32萬美元的股票。這意味着即使股票價格低於當前的9.18美元,內部人士也想套現一些股票。我們通常認爲,如果內部人員一直在銷售,尤其是在當前價格以下銷售,這是負面的,因爲這意味着他們認爲更低的價格是合理的。然而,儘管內部銷售有時會令人沮喪,但這只是一個微弱的信號。值得注意的是,這次交易佔Michael Donovan持股的50%。

Over the last year, we can see that insiders have bought 30.00k shares worth US$189k. On the other hand they divested 73.81k shares, for US$639k. In total, AxoGen insiders sold more than they bought over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

過去一年中,我們可以看到內部人士購買了價值18.9萬美元的3萬股。另一方面,他們可轉讓了7.381萬股,金額爲63.9萬美元。總體而言,AxoGen的內部人士在過去的一年中賣出的股票比買入的要多。您可以在下面看到內部交易(按公司和個人分類)在過去12個月中的視覺呈現。通過單擊下面的圖表,您可以查看每個內部交易的詳細信息!

big
NasdaqCM:AXGN Insider Trading Volume July 17th 2024
NasdaqCM:AXGN股票交易成交量2024年7月17日

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar).

如果你喜歡購買內部人員正在購買而不是銷售的股票,那麼你可能會喜歡這份免費的公司列表。(提示:它們中的大部分都被忽視了。)

Insider Ownership

內部人員持股情況

For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Insiders own 4.8% of AxoGen shares, worth about US$18m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

對於普通股東來說,值得檢查公司內部人員持有多少股份。通常情況下,持股比例越高,內部人員就越有可能爲長期建設公司提供激勵。內部人員擁有AxoGen的股份的4.8%,價值約1800萬美元。我們確實在其他地方看到了更高的內部持股比例,但這些持股足以表明內部人員與其他股東之間的一致性。

What Might The Insider Transactions At AxoGen Tell Us?

AxoGen的內部交易可能告訴我們什麼?

The fact that there have been no AxoGen insider transactions recently certainly doesn't bother us. We don't take much encouragement from the transactions by AxoGen insiders. But we do like the fact that insiders own a fair chunk of the company. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Case in point: We've spotted 1 warning sign for AxoGen you should be aware of.

事實上,最近沒有AxoGen的內部交易並不會引起我們的擔憂。AxoGen內部人士的交易並不能給我們帶來太多鼓勵。但是,我們確實喜歡內部人員擁有公司一定比例的股份的事實。因此,這些內部交易可以幫助我們建立關於股票的論點,但知道該公司面臨的風險也是值得的。例如,我們已經發現了一項AxoGen的警告信號,您應該知道。

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

如果您想查看另一家公司的信息-一家潛在具有優秀財務狀況的公司-請不要錯過這個帶有高股權回報率和低債務的有趣公司免費列表。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論